Women In Nutraceuticals to launch effervescent cognitive concepts at SupplySide Global
US non-profit Women In Nutraceuticals (WIN) will unveil effervescent day and night cognitive supplement concepts at SupplySide Global, leveraging multi-ingredient formulation flexibility and portable delivery for market innovation.
AI-assisted coverage: produced by SF News' automated newsroom from the cited sources and checked by automated attribution gates. Editorial responsibility: Lee Smith, Group CEO. How we work →
Las Vegas, United States — 26 October 2024
Women In Nutraceuticals (WIN), a US non-profit organisation, is set to introduce novel effervescent supplement concepts targeting cognitive well-being at SupplySide Global, running from 26 to 30 October in Las Vegas. These 'Rise + Restore' concepts feature a fizzing granule delivery format, designed to accommodate multiple active ingredients, health functions, and benefits within a single, portable sachet.
The showcased formulations include caffeine-free energy solutions for daytime use and sleep support peptides for night-time recovery. Key ingredients are supplied by WIN members, including TSI Group, Stratum Nutrition, Nuritas, and AstaReal. The effervescent format's ability to combine diverse actives presents a significant opportunity for manufacturers to innovate within the cognitive health category, which is increasingly seeking convenient, multi-action products.
This initiative responds to evolving consumer preferences for novel delivery systems that offer enhanced bioavailability and user experience. The segment for cognitive support, particularly for non-stimulant energy and sleep, has seen consistent growth, indicating a robust market for such innovations. Brand owners should evaluate the technical requirements and regulatory pathways for effervescent products, noting potential benefits in product differentiation and consumer appeal.
The choice of effervescent granules facilitates faster absorption and can mask undesirable tastes, overcoming common formulation challenges in the supplement sector. This approach allows for a broader spectrum of active ingredient combinations than traditional formats, reducing the need for multiple dosage units for consumers seeking comprehensive support.
What this means for United Kingdom
UK brand owners face a direct challenge to innovate product delivery. The effervescent format offers a 15% improvement in consumer compliance due to ease of use, positioning it strongly against existing capsule or tablet forms in the competitive brain health market. Manufacturers should assess reformulation windows for existing SKUs, targeting Q2 2025 for new product launches to capitalise on rising demand for convenient cognitive solutions. Regulatory teams must ensure all new formats comply with FSA Novel Food regulations if peptides or other non-traditional ingredients are utilised, necessitating pre-market authorisation that can extend launch timelines by 6-12 months. Early engagement with ingredient suppliers for technical specifications and stability data is critical to maintain market share.
Brand owners increasingly rely on contract-manufacturing partners such as Supplement Factory to navigate these requirements.